Skip to Content

Becton, Dickinson and Co - Stock Quote BDX

Rating as of

Morningstar's Becton, Dickinson and Co Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Despite Lower COVID-19 Testing and Tough Comparables, Becton, Dickinson Continues to Grow

Alex Morozov, CFA Regional Director

Analyst Note

| Alex Morozov, CFA |

We are maintaining our fair value estimate of $306 for narrow-moat Becton, Dickinson following second-quarter earnings. We currently view shares as undervalued.

Read Full Analysis

Becton, Dickinson and Co's Company Profile

Business Description

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Contact
1 Becton Drive
Franklin Lakes, NJ, 07417-1880
T +1 201 847-6800
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Mar 31, 2022
Fiscal Year End Sep 30, 2022
Stock Type Classic Growth
Employees 75,000

Becton, Dickinson and Co's Related Articles & News